T lymphocyte growth factor as a regulatory molecular for the growth and function of T lymphocytes

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology.

ESMO open·2023

[Human cells for therapeutics purpose: State of the art].

Bulletin de l'Academie nationale de medecine·2020

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020

Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid.

Journal of controlled release : official journal of the Controlled Release Society·2017

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

Bone marrow transplantation·2017

Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside.

Leukemia & lymphoma·2016

Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia.

Blood·2026

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

Blood·2026

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Blood·2026

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

Blood·2026

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Blood·2026

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Blood·2026

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Immunologic research·2026

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Archives of pathology & laboratory medicine·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Scientific reports·2026

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

PloS one·2026

Spatial statistics infer structured immune signatures in primary prostate cancer.

Cancer immunology research·2026

Related Experiment Videos

T lymphocyte growth factor as a regulatory molecular for the growth and function of T lymphocytes

Related Concept Videos

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology.

[Human cells for therapeutics purpose: State of the art].

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid.

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside.

Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia.

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

Spatial statistics infer structured immune signatures in primary prostate cancer.

Related Experiment Videos

T lymphocyte growth factor as a regulatory molecular for the growth and function of T lymphocytes

Related Concept Videos

Related Articles